NCT00045149View on ClinicalTrials.gov

Biological Therapy in Treating Patients With Metastatic Melanoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2002

Study Completion Date

June 30, 2005

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

therapeutic tumor infiltrating lymphocytes

Trial Locations (1)

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00045149 - Biological Therapy in Treating Patients With Metastatic Melanoma | Biotech Hunter | Biotech Hunter